Shiratori Y - Search Results

1

Hepatitis C virus nonstructural region 5A protein is a potent transcriptional activator.

Kato N, Lan KH, Ono-Nita SK, Shiratori Y, Omata M. Kato N, et al. Among authors: shiratori y. J Virol. 1997 Nov;71(11):8856-9. doi: 10.1128/JVI.71.11.8856-8859.1997. J Virol. 1997. PMID: 9343247 Free PMC article.

2

Hepatitis C virus NS4A and NS4B proteins suppress translation in vivo.

Kato J, Kato N, Yoshida H, Ono-Nita SK, Shiratori Y, Omata M. Kato J, et al. Among authors: shiratori y. J Med Virol. 2002 Feb;66(2):187-99. doi: 10.1002/jmv.2129. J Med Virol. 2002. PMID: 11782927

3

Hepatitis C virus core protein inhibits apoptosis via enhanced Bcl-xL expression.

Otsuka M, Kato N, Taniguchi H, Yoshida H, Goto T, Shiratori Y, Omata M. Otsuka M, et al. Among authors: shiratori y. Virology. 2002 Apr 25;296(1):84-93. doi: 10.1006/viro.2002.1371. Virology. 2002. PMID: 12036320 Free article.

4

Hepatitis C virus core protein upregulates transforming growth factor-beta 1 transcription.

Taniguchi H, Kato N, Otsuka M, Goto T, Yoshida H, Shiratori Y, Omata M. Taniguchi H, et al. Among authors: shiratori y. J Med Virol. 2004 Jan;72(1):52-9. doi: 10.1002/jmv.10545. J Med Virol. 2004. PMID: 14635011

5

Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?

Shiratori Y, Shiina S, Zhang PY, Ohno E, Okudaira T, Payawal DA, Ono-Nita SK, Imamura M, Kato N, Omata M. Shiratori Y, et al. Cancer. 1997 Dec 1;80(11):2060-7. Cancer. 1997. PMID: 9392327

6

YMDD motif in hepatitis B virus DNA polymerase influences on replication and lamivudine resistance: A study by in vitro full-length viral DNA transfection.

Ono-Nita SK, Kato N, Shiratori Y, Masaki T, Lan KH, Carrilho FJ, Omata M. Ono-Nita SK, et al. Among authors: shiratori y. Hepatology. 1999 Mar;29(3):939-45. doi: 10.1002/hep.510290340. Hepatology. 1999. PMID: 10051501

7

Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer.

Kato N, Yoshida H, Ono-Nita SK, Kato J, Goto T, Otsuka M, Lan K, Matsushima K, Shiratori Y, Omata M. Kato N, et al. Among authors: shiratori y. Hepatology. 2000 Aug;32(2):405-12. doi: 10.1053/jhep.2000.9198. Hepatology. 2000. PMID: 10915750

8

Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability.

Otsuka M, Kato N, Lan K, Yoshida H, Kato J, Goto T, Shiratori Y, Omata M. Otsuka M, et al. Among authors: shiratori y. J Biol Chem. 2000 Nov 3;275(44):34122-30. doi: 10.1074/jbc.M000578200. J Biol Chem. 2000. PMID: 10924497 Free article.

9

Novel nucleoside analogue MCC-478 (LY582563) is effective against wild-type or lamivudine-resistant hepatitis B virus.

Ono-Nita SK, Kato N, Shiratori Y, Carrilho FJ, Omata M. Ono-Nita SK, et al. Among authors: shiratori y. Antimicrob Agents Chemother. 2002 Aug;46(8):2602-5. doi: 10.1128/AAC.46.8.2602-2605.2002. Antimicrob Agents Chemother. 2002. PMID: 12121939 Free PMC article.

10

Interferons specifically suppress the translation from the internal ribosome entry site of hepatitis C virus through a double-stranded RNA-activated protein kinase-independent pathway.

Kato J, Kato N, Moriyama M, Goto T, Taniguchi H, Shiratori Y, Omata M. Kato J, et al. Among authors: shiratori y. J Infect Dis. 2002 Jul 15;186(2):155-63. doi: 10.1086/341467. Epub 2002 Jul 3. J Infect Dis. 2002. PMID: 12134250

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

641 results

Search Page

Filters